(Q38640192)

5 September 2017

title

Improving outcomes of acute myocarditis in children (English)

1 reference

5 September 2017

1 reference

Sylvie Di Filippo

1

1 reference

5 September 2017

publication date

20 November 2015

1 reference

Expert Review of Cardiovascular Therapy

5 September 2017

published in

1 reference

5 September 2017

volume

14

1 reference

5 September 2017

issue

1

1 reference

5 September 2017

page(s)

117-125

1 reference

Incidence, causes, and outcomes of dilated cardiomyopathy in children.

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2016.1114884

Pediatric patients hospitalized with myocarditis: a multi-institutional analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2016.1114884

Clinicopathological features of paediatric deaths due to myocarditis: an autopsy series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2016.1114884

Cardiovascular deaths in children: general overview from the National Center for the Review and Prevention of Child Deaths

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2016.1114884

Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2016.1114884

Viral myocarditis: from the perspective of the virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2016.1114884

21 January 2018

Update on myocarditis

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2016.1114884

Diagnosis and treatment of myocarditis in children in the current era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2016.1114884

Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2016.1114884

Matrix metalloproteinase (MMP)-9, but not MMP-2, is involved in the development and progression of C protein-induced myocarditis and subsequent dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2016.1114884

Immunomodulation and matrix metalloproteinases in viral myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2016.1114884

Diagnosis of myocarditis: death of Dallas criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2016.1114884

Role of endomyocardial biopsy for children presenting with acute systolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2016.1114884

Diagnosis and treatment of viral myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2016.1114884

The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Socie

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2016.1114884

Cardiovascular magnetic resonance in myocarditis: A JACC White Paper

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2016.1114884

Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2016.1114884

Analysis of clinical parameters and cardiac magnetic resonance imaging as predictors of outcome in pediatric myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2016.1114884

Therapy with immunoglobulin in patients with acute myocarditis and cardiomyopathy: analysis of leukocyte balance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2016.1114884

A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2016.1114884

Greater symptom duration predicts response to immunomodulatory therapy in dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2016.1114884

Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2016.1114884

Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2016.1114884

High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2016.1114884

Viral persistence in the myocardium is associated with progressive cardiac dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2016.1114884

Diagnosis and treatment of pediatric viral myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2016.1114884

Long-term follow up of patients with dilated heart muscle disease treated with human leucocytic interferon alpha or thymic hormones initial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2016.1114884

Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2016.1114884

Extracorporeal membrane oxygenation for the support of infants, children, and young adults with acute myocarditis: a review of the Extracorporeal Life Support Organization registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2016.1114884

Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2016.1114884

Early predictors of survival to and after heart transplantation in children with dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2016.1114884

Adverse consequences of high sympathetic nervous activity in the failing human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2016.1114884

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2016.1114884

Predictors of outcome in patients with suspected myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2016.1114884

Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2016.1114884

Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2016.1114884

Demographics, Trends, and Outcomes in Pediatric Acute Myocarditis in the United States, 2006 to 2011

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2016.1114884

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2016.1114884

Gamma-globulin treatment of acute myocarditis in the pediatric population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2016.1114884

10.1586/14779072.2016.1114884

21 January 2018

Identifiers

DOI

1 reference

5 September 2017

1 reference